[
  {
    "patient_ID": "TCGA.2Y.A9GV",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2233,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2304,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.2Y.A9GZ",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 719,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 842,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.2Y.A9H8",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 398,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 491,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.2Y.A9H8",
    "drug_therapy_name": "EVEROLIMUS",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 498,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 608,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.2Y.A9H8",
    "drug_therapy_name": "PASIREOTIDE",
    "pharmaceutical_therapy_type.1": "HORMONE THERAPY",
    "days_to_drug_start": 498,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 608,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.2Y.A9H9",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1017,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3K.AAZ8",
    "drug_therapy_name": "SORAFENIB",
    "days_to_drug_start": 212,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 304,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.3K.AAZ8",
    "drug_therapy_name": "REGORAFENIB",
    "days_to_drug_start": 304,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.BC.4073",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 81,
    "pharmaceutical_tx_ongoing": true,
    "drug_units": "MG",
    "drug_total_dose_units": "MG/DAY",
    "drug_dose": 400,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 800
  },
  {
    "patient_ID": "TCGA.BC.4073",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 166,
    "pharmaceutical_tx_ongoing": true,
    "drug_units": "MG",
    "drug_total_dose_units": "MG/DAY",
    "drug_dose": 200,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "DOSE REDUCTION",
    "drug_total_dose": 400
  },
  {
    "patient_ID": "TCGA.BC.A10Q",
    "drug_therapy_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type.1": "HORMONE THERAPY",
    "days_to_drug_start": 359,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 408,
    "regimen_number": 1,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.BC.A10Q",
    "drug_therapy_name": "MITOMYCIN",
    "pharmaceutical_therapy_type.1": "OTHER",
    "days_to_drug_start": 217,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 217,
    "drug_cycles": 1,
    "pharma_type_other": "CHEMOEMBOLIZATION",
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 5,
    "regimen_number": 1,
    "drug_route": "INHALATION",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "patient_ID": "TCGA.BC.A10Q",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "OTHER",
    "days_to_drug_start": 217,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 217,
    "drug_cycles": 1,
    "pharma_type_other": "CHEMOEMBOLIZATION",
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "INHALATION",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20
  },
  {
    "patient_ID": "TCGA.BC.A10Q",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 426,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 751,
    "regimen_number": 2,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.BC.A10R",
    "pharmaceutical_therapy_type.1": "OTHER",
    "days_to_drug_start": 237,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 237,
    "drug_cycles": 1,
    "pharma_type_other": "CHEMOEMBOLIZATION",
    "regimen_number": 1,
    "drug_route": "INHALATION",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.BC.A10W",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 85,
    "drug_cycles": 1,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.BC.A8YO",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 186,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.BW.A5NP",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 128,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 289,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.CC.A8HV",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 158,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 188,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DD.A115",
    "pharmaceutical_therapy_type": "PHASE II TRIAL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 502,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 841,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.DD.A11D",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 586,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 641,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DD.A11D",
    "drug_therapy_name": "VELIPARIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 709,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1105,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.DD.A11D",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1408,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1474,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DD.A1EC",
    "pharmaceutical_therapy_type": "PHASE III TRIAL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 330,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.DD.A1EG",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1154,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1310,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DD.A1EH",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 358,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 863,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DD.A1EH",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 553,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 721,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DD.A1EH",
    "drug_therapy_name": "CISPLATIN;EVEROLIMUS;GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 862,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 975,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.DD.A1EJ",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 264,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 887,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DD.A1EK",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 188,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 349,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DD.A3A4",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 459,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 486,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DD.A3A7",
    "pharmaceutical_therapy_type": "PHASE II TRIAL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 146,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 192,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.DD.A4ND",
    "drug_therapy_name": "CYCLOPHOSPHAMIDE;DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 218,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DD.A4NE",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 225,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DD.A4NH",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 162,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 305,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DD.A4NQ",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 151,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 290,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DD.A4NS",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1116,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1314,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DD.A4NS",
    "drug_therapy_name": "ABT-888",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1349,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1425,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.DD.A4NS",
    "drug_therapy_name": "LY228820",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1685,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1903,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.DD.A4NS",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1349,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1425,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.ED.A459",
    "drug_therapy_name": "ALVESIN",
    "pharmaceutical_therapy_type.1": "ANCILLARY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 103,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EP.A2KA",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 312,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FV.A3I0",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 166,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 586,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FV.A3R2",
    "drug_therapy_name": "CISPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing": false,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FV.A3R2",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing": false,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.G3.A25S",
    "drug_therapy_name": "SUNITINIB",
    "pharmaceutical_therapy_type": "OTHER",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 313,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 348,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.G3.A25S",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 351,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 369,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.G3.A3CG",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 367,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 577,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.G3.A3CH",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 717,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.G3.A3CJ",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 346,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 367,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.G3.A5SI",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 599,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 733,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.G3.AAV5",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 227,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.K7.AAU7",
    "drug_therapy_name": "GEMCITABINE",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.K7.AAU7",
    "drug_therapy_name": "CISPLATIN",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.LG.A9QD",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.UB.A7MA",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 207,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.UB.A7MA",
    "drug_therapy_name": "CISPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 207,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.UB.A7MA",
    "drug_therapy_name": "TEMSIROLIMUS",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 485,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.UB.A7MA",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 485,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.UB.A7MB",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 168,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.UB.A7MB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 187,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 382,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.UB.A7MB",
    "drug_therapy_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 480,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 510,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.UB.A7MB",
    "drug_therapy_name": "OXALIPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 480,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 510,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.UB.A7MB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 525,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.WX.AA44",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 306,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 375,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.WX.AA47",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 331,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 493,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  }
]
